Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CVS Group Plc | 4C9 | Nov 18, 2024 | 9.85 | -1.01 |
CVS HEALTH CDR(REG.S) | CVS0 | Nov 18, 2024 | 8.55 | -2.84 |
CVS Health Corporation | CVS | Nov 18, 2024 | 53.25 | +5.09 |
CVW CLEANTECH INC. | TMD0 | Nov 18, 2024 | 0.56 | 0.00 |
CY4GATE S.P.A. | 68H | Nov 18, 2024 | 3.81 | -1.81 |
Cyan AG | CYR | Nov 18, 2024 | 2.60 | -1.52 |
CyanConnode Holdings Plc | CUAN | Nov 18, 2024 | 0.09 | -7.50 |
Cyber Security 1 | 7CS | Nov 18, 2024 | 0.00 | -32.00 |
CyberAgent,Inc. | CL2 | Nov 18, 2024 | 6.00 | +1.69 |
CyberArk Software Ltd. - Ordinary Shares | CYB | Nov 18, 2024 | 295.00 | +4.72 |
CyberCatch Global | D0K | Nov 18, 2024 | 0.04 | 0.00 |
Cyberdyne Inc | 8C4 | Nov 18, 2024 | 1.09 | +8.38 |
CYBEROO S.P.A. | K97 | Nov 18, 2024 | 1.92 | -5.88 |
CYBERTRUST JAPAN | 5U2 | Nov 18, 2024 | 13.90 | +1.46 |
Cybin | R7E | Nov 18, 2024 | 13.00 | 0.00 |
Cyfrowy Polsat SA | CP9 | Nov 18, 2024 | 2.61 | -0.08 |
Cymbria Corp | CYOA | Nov 18, 2024 | 51.00 | 0.00 |
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia) | 51S | Nov 18, 2024 | 0.12 | -8.15 |
Cytokinetics, Incorporated | KK3A | Nov 18, 2024 | 47.00 | -0.84 |
Cytomed Therapeutics | F98 | Nov 18, 2024 | 1.99 | +3.11 |
CytomX Therapeutics, Inc. | 6C1 | Nov 18, 2024 | 0.83 | -5.68 |
CYTOPHAGE TECHN. LTD. | 70G | 0.00 | 0.00 | |
Cytosorbents Corporation | HQE1 | Nov 18, 2024 | 0.83 | -3.04 |
Cyviz | 8P9 | Nov 18, 2024 | 2.52 | +6.33 |
Cyxone | 4CX | Nov 18, 2024 | 0.00 | -83.33 |
CZG - Ceska Zbrojovka Group SE | 6QS | Nov 18, 2024 | 24.65 | -0.20 |
D Amico International Shipping | B7C0 | Nov 18, 2024 | 4.18 | -4.67 |
D-Box Technologies Inc. | DB2 | Nov 18, 2024 | 0.06 | -0.84 |
D-Market Electronic Services & Trading ADR | 8WZ | Nov 18, 2024 | 2.68 | -1.47 |
D-Wave Quantum | RQ0 | Nov 18, 2024 | 1.36 | -13.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.